$72.55
-0.07-0.1%
Last update: Oct 23, 5:09 PM
Bio-Techne Corp (TECH) Stock Price, Quote, News & History
TECHNASDAQ
Private equity giants circle Qiagen (QGEN) with potential bids of $50/share. Get the details on the molecular diagnostics buyout.
You can purchase shares of Bio-Techne (NASDAQ:TECH) through any online brokerage.
Other companies in Bio-Techne’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Waters Corp (NYSE:WAT).
Bio-Techne has a consensus price target of $72.17.
The stock price for Bio-Techne (NASDAQ: TECH) is $72.6 last updated October 23, 2026 at 5:09 PM EDT.
There are no upcoming dividends for Bio-Techne.
Bio-Techne does not have any upcoming earnings scheduled.
There is no upcoming split for Bio-Techne.
Bio-Techne is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and...
